It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season
The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
mRNA-1010 demonstrated superior relative vaccine efficacy
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Subscribe To Our Newsletter & Stay Updated
